Lupin Limited reported a 16% increase in net profit for the first quarter of fiscal year 2026, driven by strong performance in its domestic and international pharmaceutical segments.
Britannia Industries also posted robust results, with quarterly revenue crossing the ₹5,000 crore mark, reflecting resilient consumer demand despite inflationary pressures.
These results highlight a mixed but generally positive trend for major Indian corporations as they navigate the current economic environment and rising input costs.